The Eating Disorder Examination (EDE) is a comprehensive clinical interview for the assessment of anorexia nervosa and bulimia nervosa. The present study is the first to examine its concurrent validity by comparing it against other, primarily behavioral, measures of eating disorder symptoms. Reports of eating behavior and attitudes on the EDE were associated modestly with daily caloric intake, avoidance of regular meals, avoidance of forbidden foods, frequency and size of binge‐eating episodes, and associated highly with frequency of vomiting episodes as recorded on eating diaries. The EDE measures of body image disturbance were related strongly to self‐report questionnaires of negative body image attitudes and related modestly to body size overestimation. However, there was no evidence for incremental discriminant validity of the EDE body image scales as compared with the Body Shape Questionnaire.

Both hypertension and depression are common disorders which may both involve components of the hypothalamic-pituitary-adrenal axis system and the Renin-Angiotensin-Aldosterone System (RAAS). These observations, coupled with growing evidence that RAAS-active drugs may have anti-depressant properties prompted us to study the frequency of anti-depressant medication usage in the patients receiving RAAS-active agents. A chart review was performed on 378 patients who were seen during a 3-month period in a primary care clinic and who were diagnosed with hypertension. Demographic information and data on the rates of co-administration of antihypertensive and anti-depressant medications was collected. Overall, 23.7% of the sample was on an antidepressant. 20% of the patients taking a RAAS-modifying medication were on an antidepressant, compared to 34% of those not taking a RAAS-modifying medication (Χ(2) = 8.88, P = 0.003). The patients taking a beta-blocker alone had the highest rate of antidepressant usage (40%). The use of RAAS-modifying medications was associated with an even lower rate of anti-depressant usage in males compared with females. It was also observed that the patients taking an additional diuretic had a significantly lower rate of antidepressant use (17.6%, Χ(2) = 5.81, P = 0.016) compared with the patients not taking a diuretic. The patients being treated with an ACE inhibitor or ARB showed significantly lower rates of antidepressant usage. The data is supportive of the hypothesis that these agents may possess anti-depressant effects.

We report on a 56-year-old woman with Parkinson disease who had previously been implanted with bilateral deep brain stimulation (DBS). She was hospitalized after a 2-year course of severe depression with psychotic features and physical as well as mental decline. She underwent 2 rounds of successful electroconvulsive therapy (ECT), improving both her physical and mental health without any adverse effects to the patient or the DBS. This is a fourth reported case of ECT being successfully and safely administered in a patient implanted with DBS. This is the first case report of bitemporal ECT in a patient with bilateral DBS. It is also the first case report using the MECTA device and the first case report of a successful and safe second course of ECT after relapse of this patient's depression.

No abstract

Background-Several studies have contrasted the 16-item self-report version of the Quick Inventory of Depressive Symptomatology (QIDS-SR 16 ) with other depression scales, but none has used patients in single, large, private psychiatric practice. This study compared 175 outpatients on the QIDS-SR 16 , the 17-item Carroll Depression Rating Scale (CDRS-SR 17 , a self-report modification of the Hamilton Rating Scale for Depression), and the thirteen depression items from the Symptom Check List-90 (SCL-D 13 ). The Mini version of the Structured Clinical Interview for DSM-IV (MiniSCID) served as a "gold standard" to assess depression.